Oyster Point Pharma: This Is An Attractive Dry Eye Disease Player For 2020 [Seeking Alpha]
Oyster Point Pharma, Inc. - common stock (OYST)
Last oyster point pharma, inc. - common stock earnings: 2/27 04:01 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Today, we will see why Oyster Point Pharma ( OYST Company overview Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative treatments targeting ocular surface diseases. The company’s lead asset is OC-01, an investigational drug candidate and highly selective nAChR (nicotinic acetylcholine receptors agonist). The therapy is being developed as a nasal spray to treat the signs and symptoms of DED (dry eye disease). The company also plans to study OC-01 in NK (neurotrophic keratitis) indication, a degenerative disease in which the nerves that supply the cornea do not function properly. Why is DED a huge underserved market opportunity? There are around 34 million adults from DED in the U.S., while the global prevalence of the disease is much higher, in excess of 340 million. While 16 million DED patients have been diagnosed across the world, less than 2 million are currently being treated. To date, around 7 million pe
Show less
Read more
Impact Snapshot
Event Time:
OYST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OYST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OYST alerts
High impacting Oyster Point Pharma, Inc. - common stock news events
Weekly update
A roundup of the hottest topics